In conclusion, our study demonstrated that CREB3 suppressed the phosphorylation of AKT by competitively binding with INSR and promoting RBM38 transcription independently, thereby inhibiting HCC growth and metastasis (Figure 7F). Here, RBM38 is linked to hepatocellular carcinoma.